These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 507744)

  • 1. The effect of sequential oral contraceptive pill (Fysioquens) administration on carbohydrate and lipid metabolism.
    Vähäpassi J; Pyörälä T
    Ann Chir Gynaecol; 1979; 68(2):75-81. PubMed ID: 507744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of lynestrenol and norethindrone on the carbohydrate and lipid metabolism in subjects with gestational diabetes.
    Pyörälä T; Vähäpassi J; Huhtala M
    Ann Chir Gynaecol; 1979; 68(2):69-74. PubMed ID: 507743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of a sequential-type oral contraceptive with ethinylestradiol-sulfonate soft gelatin capsules and norethisterone acetate on carbohydrate metabolism during the first twelve months.
    Nikschick S; Göretzlehner G; Männchen E; Brachmann K
    Exp Clin Endocrinol; 1985 Jun; 85(3):257-62. PubMed ID: 3899684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraception, mechanical contraception, and carbohydrate and lipid metabolism: a two-year study.
    Pribicevic V; Skrabalo Z; Lipovac V; Trenc S; Zadjelovic J; Rajkovic Z
    Int J Fertil; 1979; 24(2):114-9. PubMed ID: 40904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modification of serum lipids and glucose tolerance by sequential Ovosiston and Minisiston].
    Vesper VB; Feustel S
    Zentralbl Gynakol; 1988; 110(4):241-5. PubMed ID: 2453102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.
    Skouby SO; Endrikat J; Düsterberg B; Schmidt W; Gerlinger C; Wessel J; Goldstein H; Jespersen J
    Contraception; 2005 Feb; 71(2):111-7. PubMed ID: 15707560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective carbohydrate metabolism studies in women using a low-estrogen oral contraceptive for one year.
    Spellacy WN; Birk SA; Buggie J; Buhi WC
    J Reprod Med; 1981 Jun; 26(6):295-8. PubMed ID: 7019435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone.
    Spellacy WN; Ellingson AB; Tsibris JC
    J Reprod Med; 1989 Aug; 34(8):540-2. PubMed ID: 2681750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined clinical, histological and stereomorphometric studies with a new oral contraceptive of normophasic type: Fysioquens.
    Dombrowicz N; Van de Walle J
    Contraception; 1980 Nov; 22(5):537-48. PubMed ID: 7009054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new oral contraceptive based on the normophasic method.
    Bolle J; Poulain A
    Arzneimittelforschung; 1976; 26(3):441-3. PubMed ID: 989342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of lowly dosed gestagen pill Exlutona on carbohydrate and fat metabolism (author's transl)].
    Loch EG; Kaiser E; Christl
    Med Klin; 1976 Oct; 71(40):1684-7. PubMed ID: 787744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desogestrel and gestodene in oral contraceptives: 12 months' assessment of carbohydrate and lipoprotein metabolism.
    Petersen KR; Skouby SO; Pedersen RG
    Obstet Gynecol; 1991 Oct; 78(4):666-72. PubMed ID: 1833682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pill formulations and their effect on lipid and carbohydrate metabolism.
    Brooks PG
    J Reprod Med; 1984 Jul; 29(7 Suppl):539-46. PubMed ID: 6481707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a continuous regimen of contraceptive combination of ethinylestradiol and drospirenone on lipid, carbohydrate and coagulation profiles.
    Machado RB; de Melo NR; Maia H; Cruz AM
    Contraception; 2010 Feb; 81(2):102-6. PubMed ID: 20103445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
    Rákóczi I; Gerö G; Demeter J; Gáti I
    Arzneimittelforschung; 1985; 35(3):630-3. PubMed ID: 3158320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormonal contraception with ethinylestradiol and gestoden. The effects on glucose tolerance and lipid metabolism].
    Petersen KR; Skouby SO; Dreisler A; Kühl C
    Ugeskr Laeger; 1987 Jun; 149(24):1614-6. PubMed ID: 3111056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term profile of a new progestin.
    Lippman J
    Int J Fertil; 1992; 37 Suppl 4():218-22. PubMed ID: 1362189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose and insulin levels during treatment with a combined oral contraceptive agent.
    Larsson-Cohn U
    Acta Soc Med Ups; 1971; 76(5-6):223-7. PubMed ID: 5141078
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
    Kamau RK; Maina FW; Kigondu C; Mati JK
    East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.